What's new :
Number of pages: 8
Publication date: November 2018
WHO reference number: WHO/CDS/GMP/MME/2018.03
Countries of the Greater Mekong Subregion (GMS) are accelerating toward their shared goal of malaria elimination by 2030. The six GMS countries – Cambodia, China (specifically Yunnan Province), the Lao People’s Democratic Republic, Myanmar, Thailand and Viet Nam – have achieved remarkable progress. Between 2012 and 2017, the reported number of malaria cases fell by 75%. Malaria deaths fell by 93% over the same period.
As the lead global technical agency, WHO supports GMS countries as they work to counter multidrug resistance and eliminate malaria. This latest WHO bulletin provides an overview of countries' achievements to date.
The Department of International Development (DFID), the Economic and Social Research Council (ESRC), the Medical Research Council (MRC) and Wellcome have jointly funded the Health Systems Research Initiative.
Types of Grants
- generate evidence on how to strengthen and improve health systems for people living in low and middle-income countries (LMIC). This may include addressing the structure and dynamics of health systems as a whole, improving the long-term resilience of the health system, in addition to generating positive improvements to systems as currently structured.
- use a health systems approach to inform the delivery of evidence-based interventions or structural changes. Proposals must demonstrate how interventions relate to and affect wider elements of a health system such as governance, financing, health workforce, information systems, service delivery.
- expand the knowledge base in understanding the structure and dynamics of health systems and provide evidence that is of direct relevance to decision makers and practitioners in the field.
- Research grants, which are larger stand-alone research projects. Proposals are expected to address clearly defined challenges faced by health systems, either within a system or in considering external influences on a system. Proposals must situate this clearly-defined challenge within an understanding of the broader health system linkages and describe how and why findings from the project have the potential to improve the health of people living in low and middle-income countries.
- Foundation grants, which are smaller (up to £200,000) and shorter (up to two years). Proposals can be either:
- exploratory, for example, looking into existing health systems and investigating the underlying causes beneath perceived problems
- to conduct pilot work to build the necessary knowledge and methodological base to support a future full proposal.
How to Apply
- Priority will be given to research that benefits the most vulnerable populations and/or those in poorly resourced settings. Whilst the funders recognise that many of the world’s poor live in middle-income countries, it is a specific objective of this programme to increase the body of research that is specifically relevant to low-income countries, whether through research in those countries or the ability to demonstrate the relevance of experience from middle-income countries to low-income countries. Applicants must illustrate how the proposed study will contribute to strengthening low-income country health systems.
- If the principal investigator (PI) is based in the UK, there must be clear partnership with, and scientific leadership from, co-investigators (Co-Is) based in the countries where the project will take place.
- Proposals should demonstrate how capacity building for junior UK and developing country staff will lead to developing future scientific leadership. Good examples of capacity-building include:
- co-design of research and implementation
- field-based research methods training for developing country partner staff
- opportunities for staff to author/co-author journal and conference papers and participate in national and international conferences
- providing mentoring to improve the capacity of Southern researchers to generate new knowledge and attain policy impact
- building organisational capacity (for example in management, financial, communications)
- institutional capacity-building (such as the incentive structures, the political and regulatory context and the resource base in which research is undertaken and used by policymakers).
- UK investigators should demonstrate an understanding of the national and local health systems context, and work harmoniously and effectively with local stakeholders to ensure the research programme does not undermine local research capacity. These factors will be taken into account by the commissioning panel.
Applicants can apply electronically via a given website. For more information, please visit Health Systems Research Initiative.
Qualitative Evaluation New Resources :
|The use of qualitative research methods fulfils an important role in the rigorous evaluation of programs. Among other contributions, qualitative methods help to illuminate “why” and “how” a program worked or not, understand program context, identify unanticipated consequences, and complement quantitative data. Recent resources from MEASURE Evaluation include a curriculum on qualitative methods in the evaluation of public health programs and a paper on measuring impact qualitatively.
Measuring Impact Qualitatively
What works and doesn’t work well with qualitative research and evaluation methods, particularly in the context of increased interest in impact evaluations? This paper, based on a document review, outlines some of the ways in which qualitative research methods are integrated into evaluations and provides insights and strategies for evaluators undertaking performance- and impact-focused evaluations.
Recent Publications :
Identifying the components of acidosis in patients with severe P. falciparum malaria using metabolomics
Journal of Infectious Disease
Loepold SJ, Ghose A, Allman EL, Kingston HWF, Hossain A, Dutta AK, Plewes K, Chotivanich K, Day NPJ, Tarning J, Winterberg M, White NJ, Llinás M, Dondorp AM
Mass drug administration for malaria elimination: do we understand the settings well enough?
Hetzel MW and Genton B
Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.
Dong Y, Wang J Sun A, Deng Y, Chen M, Xu Y, Xue J.
Diagnostic performance of salivary urea nitrogen dipstick to detect and monitor acute kidney disease in patients with malaria.
Calice-Silva V, Sacomboio E, Raimann JG, Evans R, Dos Santos Sebastião C, Tchivango AT, Kotanko P, Levin N, Pecoits-Filho R.
Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
Basuki S, Fitriah, Risamasu PM, Kasmijati, Ariami P, Riyanto S, Hidayat A, Susilowati D, Iskandar, Armika B, Budiono, Dachlan YP, Kanbara H, Uemura H
Community facilitators and barriers to a successful implementation of mass drug administration and indoor residual spraying for malaria prevention in Uganda: a qualitative study.
Wanzira H, Naiga S, Mulebeke R, Bukenya F, Nabukenya M, Omoding O, Echodu D, Yeka A.